Effectiveness Study of Physical Therapy as an Adjunct to a Lumbar Therapeutic Selective Nerve Root Block
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00934284|
Recruitment Status : Completed
First Posted : July 8, 2009
Last Update Posted : July 8, 2009
|Condition or disease||Intervention/treatment||Phase|
|Sciatic Neuropathy Radiculopathy Intervertebral Disk Displacement||Other: Lumbar injection Other: Rehabilitation following lumbar injection||Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||44 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Effectiveness of Physical Therapy as an Adjunct to a Selective Nerve Root Block in the Treatment of Lumbar Radicular Pain From Disk Herniation|
|Study Start Date :||January 2006|
|Actual Primary Completion Date :||February 2008|
|Actual Study Completion Date :||February 2008|
Active Comparator: Injection only
Participants receive a therapeutic selective nerve root block and advice to return to normal activity as tolerated.
Other: Lumbar injection
Patients are instructed to resume normal activity as tolerated.
Experimental: Injection plus physical therapy
Participants are referred to physical therapy within one week of receiving a therapeutic selective nerve root block. Physical therapy consists of end-range movements in a directional preference and/or mechanical traction to reduce radicular symptoms.
Other: Rehabilitation following lumbar injection
Participants are referred to an average of four weeks of physical therapy after receiving a lumbar injection. Physical therapy designed to include end-range directional preference exercises and/or mechanical traction to reduce lower extremity symptoms and progress activity tolerance.
- Modified Oswestry Disability Index [ Time Frame: Baseline (pre-injection), 8 weeks (post-injection), 6 months post-injection ]
- Global Rating of Change [ Time Frame: 8 weeks (post-injection) and 6 months (post-injection) ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00934284
|United States, Utah|
|Salt Lake City, Utah, United States, 84107|
|Principal Investigator:||Julie M Fritz, PhD||Associate Professor|